Kancera
  • Svenska
  • Home
  • About us
    • Statement from the CEO
    • Business model
    • Management
    • Board of directors
  • Research&Development
    • R&D portfolio
    • Fractalkine project
      • The problem
      • The solution
      • This is how KAND567 works
      • Next step
      • The future
    • Scientific publications
  • Investors
    • The share
    • Press releases
    • Reports
      • Principles and definitions
    • Calendar
    • Corporate Governance
      • Articles of association
      • General meeting
      • Board of directors committee
      • Board of directors
      • CEO and management
      • Auditors
    • Subscribe
  • Press
    • Press releases
    • Images and logos
    • Subscribe
    • News
    • Press contact
  • Contact
    • Careers
Select Page

Interim report for the fourth quarter 2019, 1 January – 31 December 2019 Kancera AB (publ.), org.nr. 556806-8851.

by kancerawebedit | Mar 2, 2020

This is a translation of the report in Swedish.Fourth quarter in brief 1 October – 31 December 2019 Net sales for the period (January to December) amounted to SEK 3,24 million (0,4 million) of which the fourth quarter contributed SEK 0,0 million (0,3 million). R&D...

Delårsrapport Kancera AB (publ) för fjärde kvartalet 2019, 1 januari – 31 december 2019.

by kancerawebedit | Feb 21, 2020

Fjärde kvartalet i korthet 1 oktober – 31 december 2019 Nettoomsättning för perioden (januari till december) uppgick till 3,2 Mkr (0,4 Mkr) varav fjärde kvartalet utgjorde 0,0 Mkr (0,3 Mkr). FoU-kostnader för perioden uppgick till 34,5 Mkr (45,2 Mkr) varav fjärde...

Year End Report Kancera AB (publ) 1st January – 31st December 2018

by kancerawebedit | Mar 6, 2019

This is a translation of the Year End Report in Swedish published February 20th 2019.FOURTH QUARTER 1st OCTOBER – 31st DECEMBER IN BRIEF • Net sales for the period (January to December) amounted to SEK 0.4 million (SEK 0.1 million), of which the fourth quarter...

Bokslutskommuniké för Kancera AB (publ) 2018, 1 januari – 31 december 2018

by kancerawebedit | Feb 22, 2019

FJÄRDE KVARTALET 1 OKTOBER – 31 DECEMBER I KORTHET • Nettoomsättning för perioden (januari till december) uppgick till 0,4 MSEK (0,1 MSEK) varav fjärde kvartalet utgjorde 0,3 MSEK (0,0 MSEK). • FoU-kostnader för perioden uppgick till 45,2 Mkr (55,8 Mkr) varav fjärde...

YEAR END REPORT KANCERA  AB (publ) 1st January – 31st December 2017

by kancerawebedit | Feb 20, 2018

PERIOD 1 JAN – 31 DEC 2017 IN BRIEF • Net turnover for the period amounted to SEK 0.1 million (0.3 million). For the fourth quarter, turnover amounted to 0.0 MEK (0.1 M). • R & D expenses for the period amounted to SEK 51.1 million (19.1 million), of which...
« Older Entries

Swedish

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

     

    Download our reports here

    Read all press releases

    Check out the latest news

    Click on the image to download our latest report

    Kancera AB

    Karolinska Institutet Science Park
    Nanna Svartz Väg 4
    SE-171 65 Solna, Sweden
    Tel: +46 (0)850 12 60 80

    This site uses cookies. Follow the link below for more information and our web policy:
    • Website policy
    • Svenska
    Copyright 2017 Kancera AB